A Psychoneuroimmunologic Perspective on AIDS Research: Questions, Preliminary Findings, and Suggestions

Journal of Applied Social Psychology

Volumn 17, Issue 3, 1987, Pages 286-308

  Solomon, George F ^a   Temoshok, Lydia ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85014974741     PISSN: 00219029     EISSN: 15591816     Source Type: Journal    
DOI: 10.1111/j.1559-1816.1987.tb00315.x     Document Type: Article

References (90)

1. Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer
2. Alexithymia: Concept and measurement
3. Depressed lymphocyte function after bereavement
4. Immunologic consequences of early exposure of experimental rodents to diethylstilbestrol and steroid hormones
5. Biopsychosocial research is essential to understanding and treating AIDS
6. Psychosocial factors and psychophysiological mechanisms in the aetiology and development of cancers
7. Psychological coping mechanisms and survival time in metastatic breast cancer
8. Sex‐dimorphic behavior in children subsequent to prenatal exposure to exogenous progestogens and estrogens
9. A unified concept of health and disease
10. Human semen inhibits T rosette formation through an opiate‐mediated mechanism
11. Induction of HTLV/LAV from a non‐virus‐producing T‐cell line: Implications for latency
12. Detection of measles virus RNA from peripheral‐blood and brain perivascular infiltrates of patients with sub‐acute sclerosing panencephalitis
13. Three essays on the theory of sexuality
14. Stress, loneliness and changes in herpes virus latency
15. Psychological response to breast cancer: Effect on outcome
16. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus
17. Hypnosis and the immune system: A review with implications for cancer and the psychology of healing
18. The thymus‐brain connection: Interactions between thymosin and the neuroendocrine system
19. Modulation of neuroendocrine circuits by thymosin peptides
20. Natural killer cells as antitumor effector cells
21. Prenatal gonadal hormones and sex differences in human behavior
22. Isolation of HTLV‐III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immune deficiency syndrome
23. The Multicenter AIDS Cohort Study (MACS): Rationale, organization, and selected characteristics of the participants
24. Psychosocial modifiers of immunocompetence in medical students
25. Urinary cortisol levels, cellular immuno‐competency, and loneliness in psychiatric inpatients
26. Stressful life events, personality and health: An inquiry into hardiness
27. Personality and constitution as mediators in the stress‐illness relationship
28. Hardiness and health: A prospective study
29. Coping and immunosuppression: Inescapable but not escapable shock suppresses lymphocyte proliferation
30. Neurological manifestations of the acquired immuno‐deficiency syndrome (AIDS): Experience at UCSF and review of the literature
31. Behavior as biological response modifier: The psycho‐immunoendocrine network and tumor immunology
32. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters
33. Neuropsychiatric aspects of acquired immune deficiency syndrome
34. Chronic immune stimulation by sperm alloantigens
35. Stressed power motivation, sympathetic activation, immune function, and illness
36. A “Type C” for cancer? Low trait anxiety in the pathogenesis of breast cancer
37. Group interventions in people with AIDS: Results of three interventions
38. Lymphocyte and granulocyte reactions during sleep deprivation
39. Coping and cancer prognosis
40. Serum IgA and emotional expression in breast cancer patients
41. Intrablood brain barrier synthesis of HTLV‐III specific Ig‐G in patients with neurological symptoms associated with AIDS or AIDS‐related complex
42. Psychoneuroendocrine influences on immunocompetence and neoplasia
43. Psychological factors in the prognosis of malignant melanoma
44. Suppression of lymphocyte stirnuation following bereavement
45. Lymphocyte function in major depressive disorder
46. The affect of hopelessness and the development of cancer
47. Psychological depression and 17‐year risk of death from cancer
48. How common is HTLV‐III infection in the United States
49. Stress and coping influence tumor growth
50. Transacting transcription of the long terminal repeat of human T lymphocyte viruses in infected cells
51. Stress and antibody response in rats
52. Emotional and personality factors in the onset and course of autoimmune disease, particularly rheumatoid arthritis
53. The emerging field of psychoneuroimmunology with a special note on AIDS
54. Psychoneuroimmunology of what to expect since CNS and immune system interact
55. Early experience and immunity
56. Emotions, immunity and disease: A speculative theoretical integration
57. The relationship of personality to the presence of rheumatoid factor in asymptomatic relatives of patients with rheumatoid arthritis
58. An intensive psychoimmunologic study of long‐surviving persons with AIDS: Pilot work, background studies, hypotheses, and methods
59. Neuroimmunomodulation
60. Human T‐cell lymphotropic virus type III in a cohort of homosexual men in New York City
61. A clinician and a scientist look at acquired immune deficiency syndrome (AIDS): A validation of immunology's theoretical foundation
62. Coping styles and other psychosocial factors related to medical status and to prognosis in patients with cutaneous malignant melanoma
63. On comparing apples, oranges, and fruit salad
64. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma
65. Stress‐behavior interactions in hamster tumor growth
66. Riskofaktoren en prevalentie van LAV/HTLV‐III antistoffen bij homoseksuele mannen in Nederland
67. Tumor rejection in rats after inescapable or escapable shock